Site 1

Houston, Texas 77030

1 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Head and Neck Squamous Cell Carcinoma

Studies at this site

• A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1) — Recruiting now
• A Study of ZN-c5 in Subjects With Breast Cancer — Completed
• A Study of ZN-c5 in Participants With Breast Cancer — Completed